Informal DIA Meeting Poll

Publishers Note
The calendar has turned to June and this year that means the Fierce team is gearing up for the big DIA and BIO annual meetings. For me, the meetings are a great way to connect with the Fierce community and to hear firsthand from the people who are developing the drugs of tomorrow. I look forward to this all year.
My preparations have made me curious so I've decided to run an informal poll. If you are doing to the DIA annual meeting send me a quick email with the following:

  • How many years have you been attending the meeting?
  • What is your area of expertise?
  • Why do you go? What do you hope to get out of it?

I'll keep your names confidential but, if we get a good response, will share the results later this week. We also have a small prize that we will give to a random respondent. I look forward to hearing from you.

Sean Griffey
Publisher, FiercePharma

P.S. If you are going to be at either DIA or BIO, drop by our free networking parties. We'd love to buy you a drink and say hello. You can RSVP here for the BIO party, and here for DIA.

Suggested Articles

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.

With two more former Insys executives facing prison time, another is claiming sexist hiring as an excuse for her role in a kickback scheme.